title: Prognostic implications of polymorphisms and interleukin-2 therapy for renal cell carcinoma.
authors.forename: Thomas A
authors.initials: TA
authors.lastname: Gardner
authors.forename: Theodore
authors.initials: T
authors.lastname: Logan
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002292:Carcinoma, Renal Cell / Q000188:drug therapy* / Q000235:genetics*; D006801:Humans; D007376:Interleukin-2 / Q000627:therapeutic use*; D007680:Kidney Neoplasms / Q000188:drug therapy* / Q000235:genetics*; D011110:Polymorphism, Genetic; D011379:Prognosis
chemical_list: D000970:Antineoplastic Agents; D007376:Interleukin-2